Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A retinitis pigmentosa that has material basis in variation in the chromosome region 4q32-q34.
Features include: Blindness, Rod-cone dystrophy, and Attenuation of retinal blood vessels.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Blindness, Attenuation of retinal blood vessels |
Biomarker and diagnostic research for retinitis pigmentosa 29 has been reported in the published literature.
No clinical trials have been registered for retinitis pigmentosa 29.
12 publications have been identified in PubMed for retinitis pigmentosa 29. Research spans Basic Science / Preclinical (25%), Review / Meta-Analysis (17%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 3 | 25% |
Data assembled from 4 of 12 sources · Last updated Sep 17, 2026, 8:41 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
2 |
17% |
Patient case studies | 2 | 17% |
Disease patterns and progression | 2 | 17% |
New treatment approaches | 2 | 17% |
Testing and diagnosis research | 1 | 8% |
Wang J (2026). [PMID: 41131664](https://pubmed.ncbi.nlm.nih.gov/41131664/). *Ophthalmic Genet*. [Case Report / Case Series]
Abu Serhan H (2026). [PMID: 41721385](https://pubmed.ncbi.nlm.nih.gov/41721385/). *Int J Retina Vitreous*. [Review / Meta-Analysis]
Hwang S (2025). [PMID: 40057012](https://pubmed.ncbi.nlm.nih.gov/40057012/). *Am J Ophthalmol*. [Basic Science / Preclinical]
Demas N (2025). [PMID: 40877827](https://pubmed.ncbi.nlm.nih.gov/40877827/). *BMC Med Genomics*. [Diagnostic / Biomarker]
Liu F (2025). [PMID: 40938072](https://pubmed.ncbi.nlm.nih.gov/40938072/). *Invest Ophthalmol Vis Sci*. [Gene Therapy / Novel Therapeutics]
Amato R (2025). [PMID: 40793857](https://pubmed.ncbi.nlm.nih.gov/40793857/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Du W (2025). [PMID: 39871419](https://pubmed.ncbi.nlm.nih.gov/39871419/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]
Fan X (2025). [PMID: 39856360](https://pubmed.ncbi.nlm.nih.gov/39856360/). *Sci Rep*. [Epidemiology / Natural History]
Hoy SM (2025). [PMID: 40540142](https://pubmed.ncbi.nlm.nih.gov/40540142/). *Mol Diagn Ther*. [Review / Meta-Analysis]
Alkan AA (2025). [PMID: 41200749](https://pubmed.ncbi.nlm.nih.gov/41200749/). *J Int Med Res*. [Epidemiology / Natural History]